Stein, Temple promoted at CDER

FDA's Office of New Drugs (OND) announced Friday the appointment of Peter Stein as director and Robert Temple in the newly created role of senior adviser in OND's Immediate Office. Stein replaces Janet Woodcock, who was OND acting director. Woodcock remains director of the Center for Drug Evaluation and Research (CDER).

Stein has been deputy director of OND since 2016...